Auliac, Jean-Bernard
Saboundji, Karima
Andre, Michel
Madelaine, Jeannick
Quere, Gilles
Masson, Philippe
Vergnenegre, Alain
Lamy, Régine
Raymond, Stéphane
Chiappa, Anne-Marie
Hauss, Pierre-Alexandre
Fournel, Pierre
Corre, Romain
Chouaid, Christos
Article History
First Online: 22 May 2019
Compliance with Ethical Standards
:
: This work was supported by an academic grant from AstraZeneca.
: JB. Auliac has received grants from AstraZeneca, Roche, and MSD and consulting fees from AstraZeneca, Bristol-Myers Squibb and Boehringer-Ingelheim. A. Vergnenegre has received fees from AstraZeneca, Hoffmann-La Roche, MSD, Bristol-Myers Squibb and Pierre Fabre Oncologie. C. Chouaid has received academic grants from AstraZeneca, Roche, Boehringer-Ingelheim and Pfizer. R. Corre, K. Saboundji, M. André, J. Madelaine, G. Quéré, P. Masson, R. Lamy, S. Raymond, A. M. Chiappa, P.-A. Hauss and P. Fournel have no conflicts of interest that are directly relevant to the content of this article.